Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's disease progression does not stop after plaque clearance; ongoing treatment with LEQEMBI can slow disease progression and prolong the benefits of therapy TOKYO and...
Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease )
Also on site :
- Beloved Country Music Star Pays Tribute To Classic Judy Garland Song With 'Somewhere Over Laredo'
- 'DWTS' Derek Hough Celebrated 40th Birthday in the Most 'Incredible' Way
- Attacks by over 100 Ukrainian drones repelled overnight – MOD